ライフサイエンスコーパス: cancer staging

1 MA-directed PET imaging will impact prostate cancer staging.

2 sts but increased efficiency and accuracy of cancer staging.

3 altered upon oncogene activation and during cancer staging.

4 sion profile and American Joint Committee on Cancer staging.

5 ckground MRI is the standard tool for rectal cancer staging.

6 ation of revised American Joint Committee on Cancer staging.

7 repeat surgery, and improve the accuracy of cancer staging.

8 icals and applications other than whole-body cancer staging.

9 an improve the prognostic accuracy of breast cancer staging.

10 h PET information, play an important role in cancer staging.

11 for multi-organ metastatic disease, and for cancer staging.

12 und guidance promises great advances in lung cancer staging.

13 igh-resolution T2-weighted MRI in esophageal cancer staging.

14 ow breathing is inadequate for comprehensive cancer staging.

15 al impact of endoscopic ultrasound in rectal cancer staging.

16 vantages of including nodal ratios in breast cancer staging.

17 nning and monitoring treatment response, and cancer staging.

18 supports wider use of SLN biopsy for breast cancer staging.

19 ssion by RT-PCR may be useful for colorectal cancer staging.

20 reening approach for PSA and PSM in prostate cancer staging.

21 s an improvement in the accuracy of prostate cancer staging.

22 tial to replace (18)F-FDG PET/CT imaging for cancer staging.

23 t common indication for the PET/CT order was cancer staging (226 cases, 75 %), with 74 % for solid an

24 ostic performance than 1.5 T MRI in prostate cancer staging (3 vs. 2), although without statistical s

25 to increase the sensitivity and accuracy of cancer staging and early detection of locoregional or sy

26 has become increasingly valuable for rectal cancer staging and inflammatory bowel disease but has ye

27 story, RB1 mutation status, 8th edition TNMH cancer staging and International Intraocular Retinoblast

28 Purpose Standard cancer staging and prognostic estimates are determined a

29 ing research published so far has focused on cancer staging and restaging in patients undergoing (18)

30 n (PSMA) PET is a powerful tool for prostate cancer staging and restaging, providing higher sensitivi

31 T combined with mostly anatomic MRI improves cancer staging and restaging.

32 ficant clinical utility by facilitating both cancer staging and treatment monitoring to more rapidly

33 tegral to patient care, forming the basis of cancer staging and treatment planning.

34 quently undergo diagnostic imaging scans for cancer staging and treatment response evaluation, which

35 s can provide important information to guide cancer staging and treatment, and thus further research

36 opharyngeal SCC underwent PET/CT for initial cancer staging and were included in the study.

37 resence of lymph node (LN) metastases guides cancer staging and worsens prognoses.

38 While anatomic imaging is critical for HN cancer staging, and frequently outweighs clinical examin

39 Coping with sampling sourced artifacts and cancer staging are among the debated topics, along with

40 gional lymph node metastases is important in cancer staging as it guides the prognosis of the patient

41 traoperative sentinel lymph node mapping for cancer staging, (b) video-angiography during surgery, an

42 The Barcelona Clinic Liver Cancer staging classification is the best at stratifying

43 Esophageal cancer staging continues to evolve, especially for advan

44 for risk assessment can improve the standard cancer staging criteria and supported the incorporation

45 as performed on 59 patients found on routine cancer staging CT scans to have unsuspected PE.

46 of patients found to have unsuspected PE on cancer staging CT scans were symptomatic.

47 Cancer staging determines extent of disease, facilitatin

48 clinic for early cancer detection, improved cancer staging, early detection of relapse, real-time mo

49 ed using the following keywords: "esophageal cancer staging," "endoscopic ultrasound," and "endoscopi

50 becoming the reference standard for prostate cancer staging, especially in advanced disease.

51 yield of (18)F-FDG PET/CT for initial breast cancer staging, even in stage II patients, whatever thei

52 increase the sensitivity and specificity of cancer staging for diagnostic and prognostic purposes.

53 as been widely used in clinical settings for cancer staging for many years, but investigations on its

54 The current American Joint Committee on Cancer staging for PTC in patients younger than age 45 y

55 s of the current American Joint Committee on Cancer staging guidelines and may be incorporated as a s

56 es that have resulted from the latest breast cancer staging guidelines and the potential impact on pr

57 s of the current American Joint Committee on Cancer staging guidelines for patients with newly diagno

58 Recently, preoperative lung cancer staging has evolved to include endobronchial ultr

59 PSMA analog radiotracers for PET/CT prostate cancer staging have been developed, such as (68)Ga-PSMA-

60 T has shown promising diagnostic accuracy in cancer staging in retrospective studies.

61 e are other indications, specifically breast cancer staging, in which MRI is being utilized with incr

62 emphasizes the radiologist's crucial role in cancer staging, including selection of appropriate imagi

63 59 194 patients with Barcelona Clinic Liver Cancer staging information, including 42 081 men (mean [

64 Integral to cancer staging is "metastasis," defined as the spread of

65 Cancer staging is an essential clinical attribute inform

66 Accurate cancer staging is essential for guiding treatment decisi

67 ttee on Cancer/Union International Contre le Cancer staging, kappa = 0.811; Enneking staging, kappa =

68 According to the American Joint Committee on Cancer Staging Manual (7(th) edition), 67 patients (93%)

69 de dissection of American Joint Committee on Cancer Staging Manual (seventh edition; AJCC-7), stage I

70 The American Joint Committee on Cancer staging manual (sixth edition) states that histol

71 wn (American Joint Committee on Cancer, AJCC Cancer Staging Manual 6th edition) first primary cutaneo

72 into the seventh edition (2009) of the AJCC Cancer Staging Manual and implemented by early 2010.

73 categories from the 7th edition of the AJCC Cancer Staging Manual and rates of toxic effects.

74 y-stage disease (American Joint Committee on Cancer Staging Manual eighth edition category T0-T2, 93%

75 , defined by the American Joint Committee on Cancer Staging Manual eighth edition staging as a Breslo

76 of American Joint Committee on Cancer (AJCC) Cancer Staging Manual for colon cancer subdivided stage

77 publication of the sixth edition of the AJCC Cancer Staging Manual in the year 2002.

78 idal melanomas in the seventh edition of the Cancer Staging Manual of the American Joint Committee on

79 h edition of the American Joint Committee on Cancer staging manual was performed by 2 readers in sepa

80 uidelines is the American Joint Committee on Cancer Staging Manual, 7th edition.

81 Using the American Joint Committee on Cancer Staging Manual, Eighth Edition, classification, t

82 criteria for invasive carcinoma based on the Cancer Staging Manual, eighth edition, from the American

83 he American Joint Committee on Cancer's AJCC Cancer Staging Manual, eighth edition, was pT1 in 341 pa

84 y) or III NSCLC (American Joint Committee on Cancer Staging Manual, seventh edition).

85 h edition of the American Joint Committee on Cancer Staging Manual.

86 nion for International Cancer Control (UICC) cancer staging manuals have resulted in confusion from c

87 may influence the next edition of AJCC/UICC cancer staging manuals will be proposed.

88 gy and widescale use of contrast imaging for cancer staging, many incidental pulmonary emboli are det

89 hing (18)F-FDG PET/MR imaging for whole-body cancer staging may be challenging because it requires mo

90 ommendations based on Barcelona Clinic Liver Cancer staging, MLTB discussion of treatment options, ap

91 ommendations based on Barcelona Clinic Liver Cancer staging, MLTB discussion of treatment options, ap

92 ients correlated with more advanced clinical cancer staging (p = 0.043) and PSA at diagnosis (p = 0.0

93 ding the current American Joint Committee on Cancer staging parameters (T-stage and sentinel node sta

94 nted of the role of CT for papillary thyroid cancer staging, possibly as an adjunct to US.

95 accuracy of 3.0 T and 1.5 T MRI in prostate cancer staging published through May 2020 were searched

96 cancer (or unknown primary cancer), initial cancer staging, restaging, and suspected cancer recurren

97 sulted in improved hemostasis, more accurate cancer staging, safer and less invasive methods of remov

98 unsuspected pulmonary emboli (PE) on routine cancer staging scans.

99 ut an applicable American Joint Committee on Cancer staging scheme were excluded.

100 for Intermediate- and High-Grade Endometrial Cancer Staging [SENTOR] study), accrual occurred from Ju

101 A preoperative lung cancer staging strategy that includes EBUS-TBNA seems to

102 ican Joint Committee on Cancer (AJCC) rectal cancer staging subdivided stage II into IIA (T3N0) and I

103 FIGO and the actual tests used for cervical cancer staging, suggesting a need to reassess the releva

104 Keywords: PET, Prostate, Molecular Imaging-Cancer, Staging Supplemental material is available for t

105 according to the American Joint Committee on Cancer staging system (6th edition) and grouped as stage

106 IA NSCLC per the American Joint Committee on Cancer staging system (7th edition) of any histology or

107 re le Cancer and American Joint Committee on Cancer staging system (7th edition).

108 previously described and validated a breast cancer staging system (CPS+EG, clinical-pathologic scori

109 oration into the American Joint Committee on Cancer staging system and better prediction of survival.

110 A long overdue revision of the breast cancer staging system becomes effective in January 2003,

111 We previously described a novel breast cancer staging system for assessing prognosis after neoa

112 The American Joint Committee on Cancer staging system for breast cancer was recently upd

113 seventh edition American Joint Committee on Cancer staging system in prognostic prediction and risk

114 viously defined and validated a novel breast cancer staging system incorporating the American Joint C

115 h edition of the American Joint Committee on Cancer staging system is prognostically robust, it shoul

116 The Barcelona Clinic Liver Cancer staging system is widely accepted and has recentl

117 Our results validate an improved breast cancer staging system that incorporates grade and ER sta

118 hould be incorporated in the pTNM esophageal cancer staging system to better predict patient outcome

119 The American Joint Committee on Cancer staging system was used to define cancer stages.

120 h edition of the American Joint Committee on Cancer staging system was used.

121 ) edition of the American Joint Committee on Cancer staging system) EGFR-mutant NSCLC were treated wi

122 re le Cancer and American Joint Committee on Cancer staging system, 7th edition).

123 e, classified as American Joint Committee on Cancer staging system, seventh edition (AJCC-7) stage II

124 porated into the American Joint Committee on Cancer staging system.

125 nsidered for the American Joint Committee on Cancer staging system.

126 into the current American Joint Committee on Cancer staging system.

127 according to the American Joint Committee on Cancer staging system.

128 a modified 1983 American Joint Committee on Cancer staging system.

129 of the KS with the modified cancer subtype, cancer staging, systemic therapy class, history of VTE,

130 The purpose of cancer staging systems is to accurately predict patient

131 arch and patient care, the evaluation of eye cancer staging systems requires international multicente

132 ensus on the optimal use and terminology for cancer staging that emerged from a consultation process

133 st notable exception was the distribution in cancer staging: the intervention group had a higher prop

134 and their margins are important for cervical cancer staging, their potential for automated cancer gra

135 s of diagnosis, American Joint Commission on Cancer staging, treatment, and outcome of patients with

136 ists in different domains including: bladder cancer staging, tumour site of origin and mislabelled ce

137 y Index, smoking status, alcohol status, and cancer staging were also considered.